Search - tctmd.com

Displaying 281 - 300 of 390

Sort: Relevancy | Date

Presentation TCT 2017

TCT 101: Safety of Double Antiplatelet Therapy as an Alternative to Warfarin Plus Aspirin After Left Atrial Appendage Device Closure - Short-Term Results of WATCHMAN-DAPT Multi-Center Registry

Presenter: Brij Maini, Petr Neuzil, Grzegorz Smolka, MD

October 31, 2017

News Conference News TCT 2017

3-D Printing Opportunities Emerge for Cardiologists, Hospitals, and Device Companies Alike

Yael L. Maxwell

October 31, 2017

Presentation TCT 2017

How to Guide LAA Closure By ICE

Presenter: Rebecca T. Hahn, Fabian Nietlispach, Brij Maini

October 30, 2017

Presentation TCT 2017

Utility of CT Before LAA Closure and How to Image

Presenter: Rebecca T. Hahn, Fabian Nietlispach, Dee Dee Wang

October 30, 2017

Presentation TCT 2017

Amulet: Data Synthesis and Ongoing Trials

Presenter: William A. Gray, Vivek Y. Reddy, Fabian Nietlispach

October 30, 2017

Presentation TCT 2017

WATCHMAN: Data Synthesis and Ongoing Trials

Presenter: William A. Gray, Vivek Y. Reddy

October 30, 2017

Presentation TCT 2017

Do the PIONEER and RE-DUAL Results Alter LAA Closure Decisions?

Presenter: William A. Gray, Vivek Y. Reddy, C. Michael Gibson

October 30, 2017

Presentation TCT 2017

Should the Improved Results With NOACs Compared to Warfarin Change LAA Closure Decisions?

Presenter: William A. Gray, Vivek Y. Reddy, Kurt Huber

October 30, 2017

Presentation TCT 2017

Debate: LAA Closure Should Be Considered in Most Patients With Nonvalvular Atrial Fibrillation!

Presenter: Christopher B. Granger, Horst Sievert, Maurice Buchbinder

October 30, 2017

Presentation TCT 2017

Debate: LAA Closure Should Be Considered Only As a Last Resort Option!

Presenter: Christopher B. Granger, Horst Sievert, John M. Mandrola

October 30, 2017

Presentation TCT 2017

LAA Closure Plus ... TAVR, MitraClip, and More

Presenter: Christopher B. Granger, Horst Sievert, Samir R. Kapadia

October 30, 2017

Presentation TCT 2017

Catheter Ablation and/or LAA Closure for Atrial Fibrillation: Competitive or Complementary?

Presenter: Christopher B. Granger, Horst Sievert, Vivek Y. Reddy

October 30, 2017

Presentation TCT 2017

Current Guidelines and Recommendations for LAA Closure in Nonvalvular Atrial Fibrillation

Presenter: Christopher B. Granger, Horst Sievert, Pascal Vranckx

October 30, 2017

Presentation TCT 2017

Strengths and Limitations of VKA and NOACs in Clinical Practice

Presenter: Christopher B. Granger, Horst Sievert

October 30, 2017

Presentation TCT 2017

LAA Closure III: Postprocedure and Beyond

Presenter: Russell A. Brandwein

October 30, 2017

Presentation TCT 2017

LAA Closure II: From Consultation to Procedure

Presenter: Russell A. Brandwein, Jessica Forman

October 30, 2017

Presentation TCT 2017

LAA Closure I: From Referral to Consultation

Presenter: Russell A. Brandwein, Lindsay Thomas

October 30, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2017

Shelley Wood

October 29, 2017

News Daily News

Complications Spiked, Then Fell, After Initial Introduction of Watchman LAA Closure Device

Todd Neale

October 12, 2017

News Conference News ESC 2017

LAACS: Surgical Closure of the Left Atrial Appendage Shows Promise

Shelley Wood

September 04, 2017

Advertisement

TCT 101: Safety of Double Antiplatelet Therapy as an Alternative to Warfarin Plus Aspirin After Left Atrial Appendage Device Closure - Short-Term Results of WATCHMAN-DAPT Multi-Center Registry

3-D Printing Opportunities Emerge for Cardiologists, Hospitals, and Device Companies Alike

How to Guide LAA Closure By ICE

Utility of CT Before LAA Closure and How to Image

Amulet: Data Synthesis and Ongoing Trials

WATCHMAN: Data Synthesis and Ongoing Trials

Do the PIONEER and RE-DUAL Results Alter LAA Closure Decisions?

Should the Improved Results With NOACs Compared to Warfarin Change LAA Closure Decisions?

Debate: LAA Closure Should Be Considered in Most Patients With Nonvalvular Atrial Fibrillation!

Debate: LAA Closure Should Be Considered Only As a Last Resort Option!

LAA Closure Plus ... TAVR, MitraClip, and More

Catheter Ablation and/or LAA Closure for Atrial Fibrillation: Competitive or Complementary?

Current Guidelines and Recommendations for LAA Closure in Nonvalvular Atrial Fibrillation

Strengths and Limitations of VKA and NOACs in Clinical Practice

LAA Closure III: Postprocedure and Beyond

LAA Closure II: From Consultation to Procedure

LAA Closure I: From Referral to Consultation

TCTMD’s Top 10 Most Popular Stories for October 2017

Complications Spiked, Then Fell, After Initial Introduction of Watchman LAA Closure Device

LAACS: Surgical Closure of the Left Atrial Appendage Shows Promise

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content